Novartis

1 trends tracked about this subject — the full history, oldest to newest below.

▲ Peaking Business

Novartis is acquiring UK-based Myricx Bio in a deal valued at up to $1.5 billion to expand its cancer-drug pipeline.

7 sources 7 articles v 5 1h ago